Vanda Pharmaceuticals Statistics
Total Valuation
VNDA has a market cap or net worth of $230.39 million. The enterprise value is $111.87 million.
| Market Cap | 230.39M |
| Enterprise Value | 111.87M |
Important Dates
The last earnings date was Wednesday, October 28, 2026, after market close.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
VNDA has 60.47 million shares outstanding. The number of shares has increased by 1.85% in one year.
| Current Share Class | 60.47M |
| Shares Outstanding | 60.47M |
| Shares Change (YoY) | +1.85% |
| Shares Change (QoQ) | +0.40% |
| Owned by Insiders (%) | 4.21% |
| Owned by Institutions (%) | 70.79% |
| Float | 46.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.00 |
| Forward PS | 0.74 |
| PB Ratio | 1.15 |
| P/TBV Ratio | 2.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.49 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.11.
| Current Ratio | 1.54 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -82.55% and return on invested capital (ROIC) is -230.56%.
| Return on Equity (ROE) | -82.55% |
| Return on Assets (ROA) | -22.61% |
| Return on Invested Capital (ROIC) | -230.56% |
| Return on Capital Employed (ROCE) | -78.25% |
| Weighted Average Cost of Capital (WACC) | 7.56% |
| Revenue Per Employee | $430,165 |
| Profits Per Employee | -$515,627 |
| Employee Count | 533 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 8.24 |
Taxes
In the past 12 months, VNDA has paid $103.63 million in taxes.
| Income Tax | 103.63M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.41% in the last 52 weeks. The beta is 0.73, so VNDA's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -12.41% |
| 50-Day Moving Average | 4.47 |
| 200-Day Moving Average | 6.00 |
| Relative Strength Index (RSI) | 40.61 |
| Average Volume (20 Days) | 1,314,541 |
Short Selling Information
The latest short interest is 7.62 million, so 12.61% of the outstanding shares have been sold short.
| Short Interest | 7.62M |
| Short Previous Month | 8.31M |
| Short % of Shares Out | 12.61% |
| Short % of Float | 16.25% |
| Short Ratio (days to cover) | 6.16 |
Income Statement
In the last 12 months, VNDA had revenue of $229.28 million and -$274.83 million in losses. Loss per share was -$4.59.
| Revenue | 229.28M |
| Gross Profit | 214.57M |
| Operating Income | -177.91M |
| Pretax Income | -171.20M |
| Net Income | -274.83M |
| EBITDA | -169.11M |
| EBIT | -177.91M |
| Loss Per Share | -$4.59 |
Balance Sheet
The company has $140.49 million in cash and $21.97 million in debt, with a net cash position of $118.52 million or $1.96 per share.
| Cash & Cash Equivalents | 140.49M |
| Total Debt | 21.97M |
| Net Cash | 118.52M |
| Net Cash Per Share | $1.96 |
| Equity (Book Value) | 199.86M |
| Book Value Per Share | 3.31 |
| Working Capital | 83.49M |
Cash Flow
In the last 12 months, operating cash flow was -$139.14 million and capital expenditures -$824,000, giving a free cash flow of -$139.96 million.
| Operating Cash Flow | -139.14M |
| Capital Expenditures | -824,000 |
| Depreciation & Amortization | 8.80M |
| Net Borrowing | -3.15M |
| Free Cash Flow | -139.96M |
| FCF Per Share | -$2.31 |
Margins
Gross margin is 93.59%, with operating and profit margins of -77.59% and -119.87%.
| Gross Margin | 93.59% |
| Operating Margin | -77.59% |
| Pretax Margin | -74.67% |
| Profit Margin | -119.87% |
| EBITDA Margin | -73.76% |
| EBIT Margin | -77.59% |
| FCF Margin | n/a |
Dividends & Yields
VNDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.85% |
| Shareholder Yield | -1.85% |
| Earnings Yield | -120.60% |
| FCF Yield | -60.75% |
Analyst Forecast
The average price target for VNDA is $11.50, which is 201.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 201.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 18.87% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VNDA has an Altman Z-Score of -1.38 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.38 |
| Piotroski F-Score | 2 |